価格表

在庫・価格 : 2025年08月20日 17時40分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-MLC-2A, Mouse-Mono(56F5)
データシート
311011 SS2シナプティックシステムズ
Synaptic Systems GmbH
100 μg ¥121,000
(未発注)
追加

在庫・価格 : 2025年08月20日 17時40分 現在

Anti-MLC-2A, Mouse-Mono(56F5)

  • 商品コード:311011
  • メーカー:SS2
  • 包装:100μg
  • 価格: ¥121,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Jung CB et al. Dantrolene rescues arrhythmogenic RYR2 defect in a patient-specific stem cell model of catecholaminergic polymorphic ventricular tachycardia. EMBO Mol Med 2012 Mar;4(3):180-91
Jung CB et al
2012/01/01
application: ICC, species: human PubMed
2 Naaijkens BA et al. Human platelet lysate as a fetal bovine serum substitute improves human adipose-derived stromal cell culture for future cardiac repair applications. Cell Tissue Res. 2012 Apr;348(1):119-30
Naaijkens BA et al
2012/01/01
application: IHC PubMed
3 Zhang J et al. Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ. Res. 2009 Feb;104(4):e30-41
Zhang J et al
2009/01/01
application: ICC PubMed
4 Rust W et al. Cardiomyocyte enrichment from human embryonic stem cell cultures by selection of ALCAM surface expression. Regen Med 2009 Mar;4(2):225-37
Rust W et al
2009/01/01
application: ICC PubMed
5 Smits AM et al. Human cardiomyocyte progenitor cell transplantation preserves long-term function of the infarcted mouse myocardium. Cardiovasc. Res. 2009 Aug;83(3):527-35
Smits AM et al
2009/01/01
application: IHC PubMed
6 Xu XQ et al. Highly enriched cardiomyocytes from human embryonic stem cells. Cytotherapy 2008;10(4):376-89
Xu XQ et al
2008/01/01
application: ICC, IHC PubMed
7 Phillips BW et al. Attachment and growth of human embryonic stem cells on microcarriers. J. Biotechnol. 2008 Nov;138(1-2):24-32
Phillips BW et al
2008/01/01
application: IHC PubMed
8 Phillips BW et al. Efficient expansion of clinical-grade human fibroblasts on microcarriers: cells suitable for ex vivo expansion of clinical-grade hESCs. J. Biotechnol. 2008 Mar;134(1-2):79-87
Phillips BW et al
2008/01/01
application: IHC PubMed
9 van Laake LW et al. Human embryonic stem cell-derived cardiomyocytes survive and mature in the mouse heart and transiently improve function after myocardial infarction. Stem Cell Res 2007 Oct;1(1):9-24
van Laake LW et al
2007/01/01
application: IHC PubMed
10 Dai W et al. Survival and maturation of human embryonic stem cell-derived cardiomyocytes in rat hearts. J. Mol. Cell. Cardiol. 2007 Oct;43(4):504-16
Dai W et al
2007/01/01
application: IHC PubMed
11 Burridge PW et al. Chemically defined generation of human cardiomyocytes. Nat. Methods 2014 Aug;11(8):855-60
Burridge PW et al
2014/01/01
application: ICC PubMed
12 Elliott DA et al. NKX2-5(eGFP/w) hESCs for isolation of human cardiac progenitors and cardiomyocytes. Nat. Methods 2011 Oct;8(12):1037-40
Elliott DA et al
2011/01/01
application: ICC PubMed
13 Herrmann F et al. Tbx5 overexpression favors a first heart field lineage in murine embryonic stem cells and in Xenopus laevis embryos. Dev. Dyn. 2011 Dec;240(12):2634-45
Herrmann F et al
2011/01/01
application: ICC PubMed
14 Lee P et al. Simultaneous voltage and calcium mapping of genetically purified human induced pluripotent stem cell-derived cardiac myocyte monolayers. Circ. Res. 2012 Jun;110(12):1556-63
Lee P et al
2012/01/01
application: ICC, FACS PubMed
15 Mehta A et al. Phasic modulation of Wnt signaling enhances cardiac differentiation in human pluripotent stem cells by recapitulating developmental ontogeny. Biochim. Biophys. Acta 2014 Nov;1843(11):2394-402
Mehta A et al
2014/01/01
application: ICC PubMed
16 Wiencierz AM et al. Differential Expression Levels of Integrin α6 Enable the Selective Identification and Isolation of Atrial and Ventricular Cardiomyocytes. PLoS ONE 2015;10(11):e0143538
Wiencierz AM et al
2015/01/01
application: FACS PubMed
17 Dorn T et al. Direct nkx2-5 transcriptional repression of isl1 controls cardiomyocyte subtype identity. Stem Cells 2015 Apr;33(4):1113-29
Dorn T et al
2015/01/01
application: ICC, IHC PubMed
18 Fanton Y et al. Cardiac atrial appendage stem cells engraft and differentiate into cardiomyocytes in vivo: A new tool for cardiac repair after MI. Int. J. Cardiol. 2015 Dec;201:10-9
Fanton Y et al
2015/01/01
application: ICC PubMed
19 Yamakawa H et al. Fibroblast Growth Factors and Vascular Endothelial Growth Factor Promote Cardiac Reprogramming under Defined Conditions. Stem Cell Reports 2015 Dec;5(6):1128-1142
Yamakawa H et al
2015/01/01
application: ICC PubMed
20 Pei F et al. Chemical-defined and albumin-free generation of human atrial and ventricular myocytes from human pluripotent stem cells. Stem Cell Res 2017 Mar;19:94-103
Pei F et al
2017/01/01
application: ICC PubMed
21 Lalit PA et al. Generation of multipotent induced cardiac progenitor cells from mouse fibroblasts and potency testing in ex vivo mouse embryos. Nat Protoc 2017 05;12(5):1029-1054
Lalit PA et al
2017/01/01
application: ICC PubMed
22 Maillet A et al. Use of Human Pluripotent Stem Cell Derived-Cardiomyocytes to Study Drug-Induced Cardiotoxicity. Curr Protoc Toxicol 2017 Aug;73:22.5.1-22.5.22
Maillet A et al
2017/01/01
application: ICC, species: human PubMed
23 Iglesias-Garc鱈a O et al. Induced pluripotent stem cells as a new strategy for cardiac regeneration and disease modeling. J. Mol. Cell. Cardiol. 2013 Sep;62:43-50
Iglesias-Garc鱈a O et al
2013/01/01
application: FACS, species: human PubMed
24 Takeda M et al. Development of In Vitro Drug-Induced Cardiotoxicity Assay by Using Three-Dimensional Cardiac Tissues Derived from Human Induced Pluripotent Stem Cells. Tissue Eng Part C Methods 2018 01;24(1):56-67
Takeda M et al
2018/01/01
application: IHC, species: stem cells PubMed
25 Clements RT et al. Phosphorylation and translocation of heat shock protein 27 and alphaB-crystallin in human myocardium after cardioplegia and cardiopulmonary bypass. J. Thorac. Cardiovasc. Surg. 2007 Dec;134(6):1461-70
Clements RT et al
2007/01/01
application: WB, IHC, species: human PubMed
26 Mummery C et al. Cardiomyocytes from human and mouse embryonic stem cells. Methods Mol. Med. 2007;140:249-72
Mummery C et al
2007/01/01
application: ICC, species: human, mouse PubMed
27 Vestergaard ML et al. Human Embryonic Stem Cell-Derived Cardiomyocytes Self-Arrange with Areas of Different Subtypes During Differentiation. Stem Cells Dev. 2017 11;26(21):1566-1577
Vestergaard ML et al
2017/01/01
application: IHC, species: human PubMed
28 Tan Y et al. Generation of clinical-grade functional cardiomyocytes from human embryonic stem cells in chemically defined conditions. J Tissue Eng Regen Med 2016 Dec;
Tan Y et al
2016/01/01
application: ICC, species: human PubMed
29 Lin Y et al. Heparin Promotes Cardiac Differentiation of Human Pluripotent Stem Cells in Chemically Defined Albumin-Free Medium, Enabling Consistent Manufacture of Cardiomyocytes. Stem Cells Transl Med 2017 Feb;6(2):527-538
Lin Y et al
2017/01/01
application: ICC, species: human PubMed
30 Krause J et al. Rat atrial engineered heart tissue: a new in vitro model to study atrial biology. Basic Res. Cardiol. 2018 09;113(5):41
Krause J et al
2018/01/01
application: IHC-P, species: rat PubMed
31 Cao Y et al. Generation of a Urine-Derived Ips Cell Line from a Patient with a Ventricular Septal Defect and Heart Failure and the Robust Differentiation of These Cells to Cardiomyocytes via Small Molecules. Cell. Physiol. Biochem. 2018;50(2):538-551
Cao Y et al
2018/01/01
application: ICC, species: mouse PubMed
32 Ting S et al. Meticulous optimization of cardiomyocyte yields in a 3-stage continuous integrated agitation bioprocess. Stem Cell Res 2018 Aug;31:161-173
Ting S et al
2018/01/01
application: IHC, species: human PubMed
33 Atmanli A et al. Multiplex live single-cell transcriptional analysis demarcates cellular functional heterogeneity. Elife 2019 10;8
Atmanli A et al
2019/01/01
PubMed
34 Halloin C et al. Continuous WNT Control Enables Advanced hPSC Cardiac Processing and Prognostic Surface Marker Identification in Chemically Defined Suspension Culture. Stem Cell Reports 2019 08;13(2):366-379
Halloin C et al
2019/01/01
PubMed
35 Branco MA et al. 3D Microwell Platform for Cardiomyocyte Differentiation of Human Pluripotent Stem Cells. Methods Mol Biol 2022;2454:127-143
Branco MA et al
2022/01/01
PubMed
36 Fukushima H et al. Specific induction and long-term maintenance of high purity ventricular cardiomyocytes from human induced pluripotent stem cells. PLoS One 2020;15(11):e0241287
Fukushima H et al
2020/01/01
PubMed
  • No.: 1
  • 文献情報:
    Jung CB et al. Dantrolene rescues arrhythmogenic RYR2 defect in a patient-specific stem cell model of catecholaminergic polymorphic ventricular tachycardia. EMBO Mol Med 2012 Mar;4(3):180-91
    Jung CB et al
    2012/01/01
  • 備考:
    application: ICC, species: human
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Naaijkens BA et al. Human platelet lysate as a fetal bovine serum substitute improves human adipose-derived stromal cell culture for future cardiac repair applications. Cell Tissue Res. 2012 Apr;348(1):119-30
    Naaijkens BA et al
    2012/01/01
  • 備考:
    application: IHC
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Zhang J et al. Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ. Res. 2009 Feb;104(4):e30-41
    Zhang J et al
    2009/01/01
  • 備考:
    application: ICC
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Rust W et al. Cardiomyocyte enrichment from human embryonic stem cell cultures by selection of ALCAM surface expression. Regen Med 2009 Mar;4(2):225-37
    Rust W et al
    2009/01/01
  • 備考:
    application: ICC
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Smits AM et al. Human cardiomyocyte progenitor cell transplantation preserves long-term function of the infarcted mouse myocardium. Cardiovasc. Res. 2009 Aug;83(3):527-35
    Smits AM et al
    2009/01/01
  • 備考:
    application: IHC
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Xu XQ et al. Highly enriched cardiomyocytes from human embryonic stem cells. Cytotherapy 2008;10(4):376-89
    Xu XQ et al
    2008/01/01
  • 備考:
    application: ICC, IHC
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Phillips BW et al. Attachment and growth of human embryonic stem cells on microcarriers. J. Biotechnol. 2008 Nov;138(1-2):24-32
    Phillips BW et al
    2008/01/01
  • 備考:
    application: IHC
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Phillips BW et al. Efficient expansion of clinical-grade human fibroblasts on microcarriers: cells suitable for ex vivo expansion of clinical-grade hESCs. J. Biotechnol. 2008 Mar;134(1-2):79-87
    Phillips BW et al
    2008/01/01
  • 備考:
    application: IHC
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    van Laake LW et al. Human embryonic stem cell-derived cardiomyocytes survive and mature in the mouse heart and transiently improve function after myocardial infarction. Stem Cell Res 2007 Oct;1(1):9-24
    van Laake LW et al
    2007/01/01
  • 備考:
    application: IHC
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Dai W et al. Survival and maturation of human embryonic stem cell-derived cardiomyocytes in rat hearts. J. Mol. Cell. Cardiol. 2007 Oct;43(4):504-16
    Dai W et al
    2007/01/01
  • 備考:
    application: IHC
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Burridge PW et al. Chemically defined generation of human cardiomyocytes. Nat. Methods 2014 Aug;11(8):855-60
    Burridge PW et al
    2014/01/01
  • 備考:
    application: ICC
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Elliott DA et al. NKX2-5(eGFP/w) hESCs for isolation of human cardiac progenitors and cardiomyocytes. Nat. Methods 2011 Oct;8(12):1037-40
    Elliott DA et al
    2011/01/01
  • 備考:
    application: ICC
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Herrmann F et al. Tbx5 overexpression favors a first heart field lineage in murine embryonic stem cells and in Xenopus laevis embryos. Dev. Dyn. 2011 Dec;240(12):2634-45
    Herrmann F et al
    2011/01/01
  • 備考:
    application: ICC
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Lee P et al. Simultaneous voltage and calcium mapping of genetically purified human induced pluripotent stem cell-derived cardiac myocyte monolayers. Circ. Res. 2012 Jun;110(12):1556-63
    Lee P et al
    2012/01/01
  • 備考:
    application: ICC, FACS
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Mehta A et al. Phasic modulation of Wnt signaling enhances cardiac differentiation in human pluripotent stem cells by recapitulating developmental ontogeny. Biochim. Biophys. Acta 2014 Nov;1843(11):2394-402
    Mehta A et al
    2014/01/01
  • 備考:
    application: ICC
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Wiencierz AM et al. Differential Expression Levels of Integrin α6 Enable the Selective Identification and Isolation of Atrial and Ventricular Cardiomyocytes. PLoS ONE 2015;10(11):e0143538
    Wiencierz AM et al
    2015/01/01
  • 備考:
    application: FACS
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Dorn T et al. Direct nkx2-5 transcriptional repression of isl1 controls cardiomyocyte subtype identity. Stem Cells 2015 Apr;33(4):1113-29
    Dorn T et al
    2015/01/01
  • 備考:
    application: ICC, IHC
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Fanton Y et al. Cardiac atrial appendage stem cells engraft and differentiate into cardiomyocytes in vivo: A new tool for cardiac repair after MI. Int. J. Cardiol. 2015 Dec;201:10-9
    Fanton Y et al
    2015/01/01
  • 備考:
    application: ICC
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Yamakawa H et al. Fibroblast Growth Factors and Vascular Endothelial Growth Factor Promote Cardiac Reprogramming under Defined Conditions. Stem Cell Reports 2015 Dec;5(6):1128-1142
    Yamakawa H et al
    2015/01/01
  • 備考:
    application: ICC
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Pei F et al. Chemical-defined and albumin-free generation of human atrial and ventricular myocytes from human pluripotent stem cells. Stem Cell Res 2017 Mar;19:94-103
    Pei F et al
    2017/01/01
  • 備考:
    application: ICC
  • 参照:
    PubMed
  • No.: 21
  • 文献情報:
    Lalit PA et al. Generation of multipotent induced cardiac progenitor cells from mouse fibroblasts and potency testing in ex vivo mouse embryos. Nat Protoc 2017 05;12(5):1029-1054
    Lalit PA et al
    2017/01/01
  • 備考:
    application: ICC
  • 参照:
    PubMed
  • No.: 22
  • 文献情報:
    Maillet A et al. Use of Human Pluripotent Stem Cell Derived-Cardiomyocytes to Study Drug-Induced Cardiotoxicity. Curr Protoc Toxicol 2017 Aug;73:22.5.1-22.5.22
    Maillet A et al
    2017/01/01
  • 備考:
    application: ICC, species: human
  • 参照:
    PubMed
  • No.: 23
  • 文献情報:
    Iglesias-Garc鱈a O et al. Induced pluripotent stem cells as a new strategy for cardiac regeneration and disease modeling. J. Mol. Cell. Cardiol. 2013 Sep;62:43-50
    Iglesias-Garc鱈a O et al
    2013/01/01
  • 備考:
    application: FACS, species: human
  • 参照:
    PubMed
  • No.: 24
  • 文献情報:
    Takeda M et al. Development of In Vitro Drug-Induced Cardiotoxicity Assay by Using Three-Dimensional Cardiac Tissues Derived from Human Induced Pluripotent Stem Cells. Tissue Eng Part C Methods 2018 01;24(1):56-67
    Takeda M et al
    2018/01/01
  • 備考:
    application: IHC, species: stem cells
  • 参照:
    PubMed
  • No.: 25
  • 文献情報:
    Clements RT et al. Phosphorylation and translocation of heat shock protein 27 and alphaB-crystallin in human myocardium after cardioplegia and cardiopulmonary bypass. J. Thorac. Cardiovasc. Surg. 2007 Dec;134(6):1461-70
    Clements RT et al
    2007/01/01
  • 備考:
    application: WB, IHC, species: human
  • 参照:
    PubMed
  • No.: 26
  • 文献情報:
    Mummery C et al. Cardiomyocytes from human and mouse embryonic stem cells. Methods Mol. Med. 2007;140:249-72
    Mummery C et al
    2007/01/01
  • 備考:
    application: ICC, species: human, mouse
  • 参照:
    PubMed
  • No.: 27
  • 文献情報:
    Vestergaard ML et al. Human Embryonic Stem Cell-Derived Cardiomyocytes Self-Arrange with Areas of Different Subtypes During Differentiation. Stem Cells Dev. 2017 11;26(21):1566-1577
    Vestergaard ML et al
    2017/01/01
  • 備考:
    application: IHC, species: human
  • 参照:
    PubMed
  • No.: 28
  • 文献情報:
    Tan Y et al. Generation of clinical-grade functional cardiomyocytes from human embryonic stem cells in chemically defined conditions. J Tissue Eng Regen Med 2016 Dec;
    Tan Y et al
    2016/01/01
  • 備考:
    application: ICC, species: human
  • 参照:
    PubMed
  • No.: 29
  • 文献情報:
    Lin Y et al. Heparin Promotes Cardiac Differentiation of Human Pluripotent Stem Cells in Chemically Defined Albumin-Free Medium, Enabling Consistent Manufacture of Cardiomyocytes. Stem Cells Transl Med 2017 Feb;6(2):527-538
    Lin Y et al
    2017/01/01
  • 備考:
    application: ICC, species: human
  • 参照:
    PubMed
  • No.: 30
  • 文献情報:
    Krause J et al. Rat atrial engineered heart tissue: a new in vitro model to study atrial biology. Basic Res. Cardiol. 2018 09;113(5):41
    Krause J et al
    2018/01/01
  • 備考:
    application: IHC-P, species: rat
  • 参照:
    PubMed
  • No.: 31
  • 文献情報:
    Cao Y et al. Generation of a Urine-Derived Ips Cell Line from a Patient with a Ventricular Septal Defect and Heart Failure and the Robust Differentiation of These Cells to Cardiomyocytes via Small Molecules. Cell. Physiol. Biochem. 2018;50(2):538-551
    Cao Y et al
    2018/01/01
  • 備考:
    application: ICC, species: mouse
  • 参照:
    PubMed
  • No.: 32
  • 文献情報:
    Ting S et al. Meticulous optimization of cardiomyocyte yields in a 3-stage continuous integrated agitation bioprocess. Stem Cell Res 2018 Aug;31:161-173
    Ting S et al
    2018/01/01
  • 備考:
    application: IHC, species: human
  • 参照:
    PubMed
  • No.: 33
  • 文献情報:
    Atmanli A et al. Multiplex live single-cell transcriptional analysis demarcates cellular functional heterogeneity. Elife 2019 10;8
    Atmanli A et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 34
  • 文献情報:
    Halloin C et al. Continuous WNT Control Enables Advanced hPSC Cardiac Processing and Prognostic Surface Marker Identification in Chemically Defined Suspension Culture. Stem Cell Reports 2019 08;13(2):366-379
    Halloin C et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 35
  • 文献情報:
    Branco MA et al. 3D Microwell Platform for Cardiomyocyte Differentiation of Human Pluripotent Stem Cells. Methods Mol Biol 2022;2454:127-143
    Branco MA et al
    2022/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 36
  • 文献情報:
    Fukushima H et al. Specific induction and long-term maintenance of high purity ventricular cardiomyocytes from human induced pluripotent stem cells. PLoS One 2020;15(11):e0241287
    Fukushima H et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed